Miami Valves 2016 : An Annual International Conference on Transcatheter Therapies of Valvular and Structural Heart Disease

Miami Valves 2016 : An Annual International Conference on Transcatheter Therapies of Valvular and Structural Heart Disease is organized by University of Miami Health System and would be held during Oct 6 - 8, 2016 at Miami Marriott Biscayne Bay, Miami, Florida, United States of America.

The target audience for this medical event basically for Interventional and invasive cardiologists, general cardiologists, cardiovascular surgeons, vascular surgeons, interventional radiologists, physicians, nurses, technologists and healthcare professionals with an interest in cardiovascular disease, structural heart disease therapies, vascular medicine and thoracic surgery. This CME Conference has been approved with a maximum of 17.25 AMA PRA Category 1 Credits offering.

Miami Valves 2016 showcases the latest in Transcatheter Valve Replacement and is the natural progression of the University of Miami’s Masters in Repair of Structural Heart Disease (MIRS) Conference which has a long history of excellence. Miami Valves 2016 will update medical professionals on the latest systems, techniques and practices to ensure safe and effective Transcatheter Valve Replacement.

Highlights :

• Transcatheter Aortic Valve Replacement A-Z: From Planning to Complications
• Edge to Edge Mitral Valve Repair
• Novel Transcatheter Tricuspid Regurgitation Therapies
• Transcatheter Therapies for Secondary Stroke Prevention
• High Risk Percutaneous Intervention: From Plaque Modification to Left Ventricular Assist Devices
• Innovation in Structural Heart Disease Therapies Objectives :

• Appraise new and upcoming technologies in the management of structural heart disease, including valvular heart disease, stroke prevention, hemodynamic support, cardiomyopathy and highrisk percutaneous coronary intervention to determine their benfit for patients
• Evaluate the relative advantages and disadvantages of different strategies in complex cases involving valvular disease
• Present indications, techniques, outcomes, and complications for transcatheter valve intervention in patients with native valve lesions
• Compare FDA approved technologies for TAVR and the scientific data supporting their use
• Examine best practice techniques for high certainty valve implantation
• Analyze data and techniques for treatment of bioprosthetic valve dysfunction